Differences in vascular reactivity between pregnant women with chronic hypertension and preeclampsia

Hypertension Research

Volumn 37, Issue 2, 2014, Pages 145-150

  Mori, Toshitaka ^a   Watanabe, Kazushi ^a   Iwasaki, Ai ^a   Kimura, Chiharu ^a   Matsushita, Hiroshi ^a   Shinohara, Koichi ^a   Wakatsuki, Akihiko ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic hypertension; endothelial dysfunction; intima media thickness; oxidative stress; preeclampsia

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MATERNAL HYPERTENSION; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; VASODILATATION;

ADULT; ARTERIES; BLOOD GLUCOSE; BLOOD VESSELS; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HEMODYNAMICS; HEMOGLOBINS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LIPIDS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84893715999     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.131     Document Type: Article

References (36)

1. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533-538.
2. Mori T, Shinohara K, Wakatsuki A, Watanabe K, Fujimaki A. Adipocytokines and endothelial function in preeclamptic women. Hyperten Res 2010; 33: 250-254.
3. Watanabe K, Okatani Y, Sagara Y. Potentiating effect of hydrogen peroxide on the serotonin-induced vasocontraction in human umbilical artery. Acta obstet Gynecol Scand 1996; 75: 783-789.
4. Okatani Y, Watanabe K, Sagara Y. Effect of nitric oxide, prostacyclin, and thromboxane on the vasospastic action of hydrogen peroxide on human umbilical artery. Acta obstet Gynecol Scand 1997; 76: 515-520.
5. Watanabe K, Mori T, Iwasaki A, Kimura C, Matsushita H, Shinohara K, Wakatsuki A. Increased oxidant generation in the metabolism of hypoxanthine to uric acid and endothelial dysfunction in early-onset and late-onset preeclamptic women. J Matern Fetal Neonatal Med 2012; 25: 2662-2666.
6. Bdolah Y, Karumanchi SA, Sachs BP. Recent advances in understanding of pre-eclampsia. Croat Med J 2005; 46: 728-736.
7. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999; 354: 810-816.
8. Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004; 44: 374-380.
9. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Exp Biol Med 1999; 222: 222-235.
10. Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009; 23: S38-S42.
11. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-816.
12. Beguml R. Lipid peroxidation and antioxidant status in preeclampsia. J Enam Med Col 2011; 1: 56-59.
13. Watanabe K, Mori T, Wakatsuki A, Kimura C, Iwasaki A. Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hyperten Res 2013; 36: 356-360.
14. Fujimaki A, Watanabe K, Mori T, Kimura C, Shinohara K, Wakatsuki A. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta 2011; 32: 367-372.
15. Kimura C, Watanabe K, Iwasaki A, Mori T, Matsushita H, Shinohara K, Wakatsuki A. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med 2012; 26: 491-496.
16. Matthias WL, Hugh SM, Michiel LB. Prediction of clinical cardiovascular events with carotid intima-media thickness. a systematic review and meta-analysis. Circulation 2007; 115: 459-467.
17. Pierluigi C, Pasquale PF, Enrico V. Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol 2010; 56: 2006-2020.
18. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100: 369-377.
19. Panza JA, Casno PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-1474.
20. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008; 51: 1002-1009.
21. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
22. Trotti R, Carratelli M, Barbieri M. Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Med 2002; 44: 37-40.
23. Parmigiani S, Payer C, Massari A, Bussolati G, Bevilacqua G. Normal values of reactive oxygen metabolites on the cord-blood of fullterm infants with a colorimetric method. Acta Biomed Ateneo Parmense 2000; 71: 59-64.
24. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela I, Barsotti A, Terranova R, Nicolaides A. A simple test to monitor oxidative stress. Int Angiol 1998; 18: 127-130.
25. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-H1149.
26. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-265.
27. Boutouyrie P, Laurent S, Girerd X. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25: 651-659.
28. Watanabe K, Iwasaki A, Mori T, Kimura C, Matsushita H, Shinohara K, Wakatsuki A. Differences in levels of oxidative stress in mothers and neonate: the impact of mode of delivery. J Matern Fetal Neonatal Med 2013 (in press).
29. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 1998; 19: 581-586.
30. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20: 159-169.
31. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-1474.
32. Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, Lawlor DA. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation 2012; 125: 1367-1380.
33. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, Price K, Karumanchi SA, Valdés G. Endothelial dysfunction a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49: 90-95.
34. Yinon Y, Kingdom JCP, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZ, Hladunewich MA. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: Insights into future vascular risk. Circulation 2010; 122: 1846-1853.
35. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens 2007; 25: 2301-2307.
36. Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006; 24: 751-756.